PAMU
NBP

Pictet Asset Management (UK)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Pictet Asset Management (UK)’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3.12M Buy
+37,200
New +$2.45M ﹤0.01% 936

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
WFM Asia Road Town, Tortola, British Virgin Islands $632M AUM 14.51% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Pictet Asset Management (UK)'s NBP Position: Q2 2021 in Review

Pictet Asset Management (UK) opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2021: 37,200 shares worth $3.12M. The stake represents ﹤0.01% of the portfolio and ranks #936 among its holdings.

136 funds tracked by Wall St. Rank hold NBP as of Q2 2021.

  • Pictet Asset Management (UK) held 37,200 shares of NovaBridge Biosciences American Depositary Shares worth $3.12M as of Q2 2021.
  • NovaBridge Biosciences American Depositary Shares was a new Pictet Asset Management (UK) position in Q2 2021.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #936 holding.
  • 136 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.